Wuxi Biologics (Cayman) Inc(WXIBF)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

WXIBF Wuxi Biologics (Cayman) Inc

盘前交易 02-10 16:00:00 EST 延时

{"stockData":{"symbol":"WXIBF","market":"US","secType":"STK","nameCN":"Wuxi Biologics (Cayman) Inc","latestPrice":5.2,"timestamp":1770757200000,"preClose":4.2785,"halted":0,"volume":202000,"delay":15,"changeRate":0.21537922168984455,"floatShares":3732868601,"shares":4137541236,"eps":0.107499,"marketStatus":"盘前交易","change":0.9215,"latestTime":"02-10 16:00:00 EST 延时","open":5.1,"high":5.2,"low":5.1,"amount":1039890,"amplitude":0.023373,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.107499,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770820200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":5.2,"volumeRatio":7.636358100107114},"requestUrl":"/m/hq/s/WXIBF/tweets","defaultTab":"tweets","newsList":[{"id":"2584972045","title":"美国OTC市场药明生物盘中异动 急速跳水7.56%报4.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584972045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584972045?lang=zh_cn&edition=full","pubTime":"2025-11-19 23:29","pubTimestamp":1763566140,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日23时29分，美国OTC市场药明生物股票出现异动，股价大幅下挫7.56%。截至发稿，该股报4.16美元/股，成交量840股，换手率0.00%，振幅0.00%。美国OTC市场药明生物股票所在的生物技术行业中，整体跌幅为0.25%。美国OTC市场药明生物公司简介：无锡药明康德集团是一家生物药物的合同开发和制造组织，简称“CDMO”。无锡药明康德报告称，2020年收入为56亿元人民币，三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119232901a704b14c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119232901a704b14c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXIBF"],"gpt_icon":0},{"id":"2577434908","title":"美国OTC市场药明生物盘中异动 大幅跳水6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577434908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577434908?lang=zh_cn&edition=full","pubTime":"2025-10-22 22:52","pubTimestamp":1761144720,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日22时52分，美国OTC市场药明生物股票出现波动，股价急速下挫6.15%。美国OTC市场药明生物股票所在的生物技术行业中，整体跌幅为0.36%。美国OTC市场药明生物公司简介：无锡药明康德集团是一家生物药物的合同开发和制造组织，简称“CDMO”。它成立于 2010 年，隶属于药明康德，并于 2017 年在香港联交所上市。无锡药明康德报告称，2020年收入为56亿元人民币，三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022225201a46ec888&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022225201a46ec888&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXIBF","BK4121"],"gpt_icon":0},{"id":"2577633992","title":"创新药License-out火爆，价值重估进行时","url":"https://stock-news.laohu8.com/highlight/detail?id=2577633992","media":"同壁财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577633992?lang=zh_cn&edition=full","pubTime":"2025-10-22 11:15","pubTimestamp":1761102906,"startTime":"0","endTime":"0","summary":"医药魔方数据显示，2025年上半年License-out交易达72笔，已超2024年全年总量的一半；交易总金额较2024年全年高出16%，其中单笔超10亿美元的交易共16笔。License-out同期首付款总额首次超过一级市场融资总额，成为Biotech企业资金回流的关键路径，BD出海正逐步成为Biotech不可或缺的“输血”渠道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022111705a46d83ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022111705a46d83ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2045819591.USD","LU0320764599.SGD","LU0052750758.USD","LU1046422090.SGD","BK1576","02359","BK1574","BK1141","BK1583","LU2125910500.SGD","02269","LU2242644610.SGD","BK1161","WXIBF","LU0708995583.HKD","06978"],"gpt_icon":0},{"id":"2570852976","title":"CXO，一定要出去抢！","url":"https://stock-news.laohu8.com/highlight/detail?id=2570852976","media":"谈思生物","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570852976?lang=zh_cn&edition=full","pubTime":"2025-09-27 11:00","pubTimestamp":1758942050,"startTime":"0","endTime":"0","summary":"既然药圈高处不胜寒，干脆换个赛道，蹲一蹲 CXO 的“洼地”。把视野放大，扫了眼国内 CXO 出海战绩，又对照了 Lonza 这类全球龙头，心里大概有了粗线条图景。如图，净利润同比飙升54.8%，增速相当惹眼。倘若把全球CXO的终局比作一条终点线，药明生物的赛程才跑到一半——Ⅲ期收入占比尚未过半，天花板还远在天边。微观来看，这是重写CXO世界版图；宏观而言，更是在撬动现有国际规则——只有把旧秩序撕开裂缝，中国产业链才算真正跨出国门。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927111944a6a165e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927111944a6a165e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0327786744.USD","LU0359202008.SGD","LU0516423174.USD","LU0708995583.HKD","LU1880383366.USD","LU0181495838.USD","WXIBF","LU0052750758.USD","LU0823426480.USD","BK1610","LU0516423091.SGD","02269","LU1688375341.USD","LU0819121731.USD","LU0823426308.USD","LU1794554557.SGD","LU0417516738.SGD","LU0359201612.USD","LU0326950275.SGD","LU0320764599.SGD","LU0572944931.SGD","SG9999002463.SGD","IE00B0JY6N72.USD","LU1242518857.USD","LU0348735423.USD","LU0516422952.EUR","LU0348825331.USD","LU0307460666.USD","LU0856984785.SGD","BK1141","LU0979878070.USD","LU1242518931.SGD","LU0456827905.SGD","BK1589","LU2039709279.SGD","BK1521","SG9999002562.SGD","BK1576","LU0456846285.SGD","LU0516422440.USD","LU0417516902.SGD","LU1720050803.USD","LU0516422366.SGD","LU0043850808.USD","LU0588546209.SGD","LU0039217434.USD","LU0051755006.USD","LU0140636845.USD"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.1576},{"period":"6month","weight":-0.0314},{"period":"1year","weight":0.3021},{"period":"ytd","weight":0.6619}],"exchange":"PINK LIMITED","name":"Wuxi Biologics (Cayman) Inc","nameEN":"Wuxi Biologics (Cayman) Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Wuxi Biologics (Cayman) Inc(WXIBF)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Wuxi Biologics (Cayman) Inc(WXIBF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Wuxi Biologics (Cayman) Inc,WXIBF,Wuxi Biologics (Cayman) Inc股票,Wuxi Biologics (Cayman) Inc股票老虎,Wuxi Biologics (Cayman) Inc股票老虎国际,Wuxi Biologics (Cayman) Inc行情,Wuxi Biologics (Cayman) Inc股票行情,Wuxi Biologics (Cayman) Inc股价,Wuxi Biologics (Cayman) Inc股市,Wuxi Biologics (Cayman) Inc股票价格,Wuxi Biologics (Cayman) Inc股票交易,Wuxi Biologics (Cayman) Inc股票购买,Wuxi Biologics (Cayman) Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Wuxi Biologics (Cayman) Inc(WXIBF)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Wuxi Biologics (Cayman) Inc(WXIBF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}